Course: Perspectives on Selected Myasthenia Gravis Posters and Abstracts From the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)
CME Credits: 0.75
Released: 2024-11-20
Myasthenia gravis, an autoimmune disease characterized by fluctuating muscle weakness, greatly impacts patients’ functioning and activities of daily living. Important treatment advances continue to be made to reduce patient burden of disease and overcome safety, efficacy, and other limitations of available therapies. Join Nicholas Silvestri, MD, as he reports on research results of some of these advances presented at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting. In addition to describing the methods and results of four studies presented at the meeting, Dr. Silvestri provides his expert comments on the clinical implications of each study.
Upon completion of this activity, participants should be better able to:
View Full Course